Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition
International Immunopharmacology · 2023-05 · 118 · 110064
DOI: 10.1016/j.intimp.2023.110064 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Shuling Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Metastasis is one of the most difficult challenges for clinical lung cancer treatment. Epithelial-mesenchymal transition (EMT) is the crucial step of tumor metastasis. Immune cells in the tumor microenvironment (TME), such as tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), promote cancer cell EMT. In this study, we explored the effect of methionine enkephalin (MENK) on the EMT process in vitro and in vivo, and its influence on TAMs, MDSCs, and associated cytokines in vivo. The results showed that MENK suppressed growth, migration, and invasion of lung cancer cells and inhibited the EMT process by interacting with opioid growth factor receptor. MENK reduced the number of M2 macrophages and MDSC infiltration, and downregulated the expression of interleukin-10 and transforming growth factor-β1 in both primary and metastatic tumors of nude mice. The present findings suggest that MENK is a potential target for suppressing metastasis in lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of Ophthalmology, The First Hospital of China Medical University, Shenyang 110001, China.
- Department of Immunology, School of Basic Medical Science, China Medical University, Shenyang 110122, China.
- Immune Therapeutics Inc., 2431 Aloma Ave #124, Winter Park, FL 32792, USA.
- Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of Gastroenterological Endoscopy, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address: wangxu@cmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S., Geng, J., Shan, F., Shan, Y., Griffin, N., Wu, B., & Wang, X. (2023). Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition. International Immunopharmacology, 118, 110064. https://doi.org/10.1016/j.intimp.2023.110064
Vancouver
Zhang S, Geng J, Shan F, Shan Y, Griffin N, Wu B, et al. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition. International Immunopharmacology. 2023;118:110064. doi:10.1016/j.intimp.2023.110064
BibTeX
@article{Zhang2023,
author = {Zhang, Shuling and Geng, Jin and Shan, Fengping and Shan, Yuanye and Griffin, Noreen and Wu, Bin and Wang, Xu},
title = {Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition},
journal = {International Immunopharmacology},
year = {2023},
volume = {118},
pages = {110064},
doi = {10.1016/j.intimp.2023.110064}
}
EUVIMED